Table 6:

Treatments on Cumulative Mean Adherence Including Post-Incentives (Months 2 – 26)

	(1)	(2)	(3)	(4)	(5)	(6)	(7)
	(OLS)	(OLS)	(Tobit)	(Tobit)	Mean Adherence	Mean Adherence	Mean Adherence
	Mean Adherence	Mean Adherence	Mean Adherence	Mean Adherence	25^th Quantile	50^th Quantile	75^th Quantile
Tl group	0.0490 (0.049)	0.0682 (0.049)	0.0365 (0.046)	0.0532 (0.045)	0.0368 (0.103)	0.0286 (0.059)	0.0302 (0.031)
T2 group	0.1246^*** (0.046)	0.1263^** (0.048)	0.0921^** (0.042)	0.1063^** (0.047)	0.1507 (0.106)	0.0591 (0.049)	0.0559^** (0.024)
Controls included	No	Yes	No	Yes	Yes	Yes	Yes
Observations	60	60	60	60	60	60	60
Mean (Qntl.) of dep var	0.833	0.833	0.833	0.833	0.723	0.875	0.938

Standard errors in parentheses

p < 0.10,

^**

p < 0.05,

^***

p < 0.01

Notes: This table presents the coefficient estimates from both OLS and Tobit (censored) regression models of cumulative mean ARV adherence over the 20-month intervention and 6 months post-incentives on indicator variables for the two treatment groups, estimated using heteroscedasticity-consistent standard errors. Columns 1 and 3 (2 and 4) show the coefficients from the models estimated without (and with) demographic controls that include participants’ age, gender, education, marital status, a measure of household assets, home ownership status, monthly income, travel costs to the clinic, household size, measures of physical and mental health, intrinsic motivation, and present-biased preferences. Columns 5 – 7 display coefficients from the same model estimated with all of the demographic controls as a quantile regression at the 25^th, 50^th, and 75^th percentiles of cumulative ARV adherence over months 2 – 26. The average cumulative ARV adherence over months 2 –26 was 83.3% among the full sample (N=60).